News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Priscilla Velentgas, PhD

Articles by Priscilla Velentgas, PhD

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD

December 8th 2021

Latest Updated Articles

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
Published: December 8th 2021 | Updated:
eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
Published: December 8th 2021 | Updated:

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.